Mirae Asset Global Investments
IMGN

Mirae Asset Global Investments’s Immunogen Inc IMGN Stock Holding History

Mirae Asset Global Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-127,205
Closed -$3.77M – 2699
2023
Q4 		$3.77M Sell
127,205
-6,934
-5% -$138K 0.01% 988
2023
Q3 		$2.13M Buy
134,139
+11,976
+10% +$199K ﹤0.01% 1150
2023
Q2 		$2.3M Sell
122,163
-23,651
-16% -$279K ﹤0.01% 1144
2023
Q1 		$560K Buy
145,814
+51,686
+55% +$220K ﹤0.01% 1867
2022
Q4 		$467K Buy
94,128
+78
+0.1% +$423 ﹤0.01% 1931
2022
Q3 		$449K Buy
94,050
+27,253
+41% +$144K ﹤0.01% 1932
2022
Q2 		$300K Buy
+66,797
New +$290K ﹤0.01% 1989

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global Investments's IMGN Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 127,205 shares — an estimated $3.77M sold.

Mirae Asset Global Investments first reported a position in IMGN in Q2 2022 and held it in 7 quarters. The position peaked at $3.77M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 127,205 Immunogen Inc shares in Q1 2024, an estimated $3.77M.
  • Mirae Asset Global Investments first reported a position in Immunogen Inc in Q2 2022 and held it in 7 quarters.
  • Mirae Asset Global Investments's Immunogen Inc position peaked at $3.77M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.